XML 31 R6.htm IDEA: XBRL DOCUMENT v3.24.1
CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY (DEFICIT) - USD ($)
$ in Thousands
Total
Series A-1 Preferred Stock
Series A-2 And A-3 Preferred Stock
Previously Reported
Revision of Prior Period, Adjustment
Series Seed Convertible Preferred Stock
Series Seed Convertible Preferred Stock
Previously Reported
Series Seed Convertible Preferred Stock
Revision of Prior Period, Adjustment
Class A Common Stock
Class A Common Stock
Series A-1 Preferred Stock
Class A Common Stock
Series A-2 And A-3 Preferred Stock
Class A Common Stock
Previously Reported
Class A Common Stock
Revision of Prior Period, Adjustment
Additional Paid-in Capital
Additional Paid-in Capital
Series A-1 Preferred Stock
Additional Paid-in Capital
Series A-2 And A-3 Preferred Stock
Additional Paid-in Capital
Previously Reported
Additional Paid-in Capital
Revision of Prior Period, Adjustment
Subscription Receivable
Subscription Receivable
Previously Reported
Retained Deficit
Retained Deficit
Previously Reported
Non- controlling Interest
Non- controlling Interest
Previously Reported
Shares outstanding, beginning balance (in shares) at Dec. 31, 2021           0 3,981,236                                  
Shares outstanding, beginning balance (in shares) (Retroactive application of conversion of Series Seed to Class A Common Stock) at Dec. 31, 2021               (3,981,000)                                
Shares, outstanding, beginning balance (in shares) at Dec. 31, 2021                 11,268,877     7,120,208                        
Shares, outstanding, beginning balance (in shares) (Retroactive application of conversion of Series Seed to Class A Common Stock) at Dec. 31, 2021                         4,041,282                      
Shares, outstanding, beginning balance (in shares) (Retroactive application of recapitalization (note 1)) at Dec. 31, 2021                         107,387                      
Shareholders' equity, beginning balance at Dec. 31, 2021 $ 7,910     $ 7,910   $ 0 $ 4   $ 1     $ 7   $ 5,134     $ 5,124   $ (50) $ (50) $ (1,473) $ (1,473) $ 4,298 $ 4,298
Shareholders' equity, beginning balance (Retroactive application of conversion of Series Seed to Class A Common Stock) at Dec. 31, 2021         $ 0     $ (4)                   $ 4            
Shareholders' equity, beginning balance (Retroactive application of recapitalization (note 1)) at Dec. 31, 2021         $ 0               $ (6)         $ 6            
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                                
Cash collected from subscription receivable 35                                   35          
Stock-based compensation 17                         17                    
Change in ownership interest in former subsidiary 34                         34                    
Deconsolidation of former subsidiaries $ (4,265)                                              
Exercise of stock options (in shares) 0                                              
Net Loss $ (9,400)                                       (9,367)   (33)  
Shares, outstanding, ending balance (in shares) at Dec. 31, 2022 11,268,877               11,268,877                              
Shareholders' equity, ending balance at Dec. 31, 2022 $ (5,669)               $ 1         5,185         (15)   (10,840)   0  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                                
Cash collected from subscription receivable 15                                   15          
Stock-based compensation 82                         82                    
Change in ownership interest in former subsidiary 0                                              
Issuance of common stock to employees (in shares)                 9,441                              
Issuance of common stock to employees 94                         94                    
Stock issued during period (in shares)                 8,650,969                              
Reverse recapitalization, net of transaction costs $ 10,462               $ 1         10,461                    
Exercise of stock options (in shares) 207,392               207,341                              
Exercise of stock options $ 23                         23                    
Issuance of preferred Series A-1, A-2, A-3 shares, converted to Class A common stock following business combination (in shares)                   2,447,453 5,459,368                          
Issuance of preferred Series A-1, A-2, A-3 shares, converted to Class A common stock following business combination   $ 24,204 $ 38,362               $ 1       $ 24,204 $ 38,361                
Net Loss $ (52,822)                                       (52,822)      
Shares outstanding, ending balance (in shares) at Dec. 31, 2023 0                                              
Shares, outstanding, ending balance (in shares) at Dec. 31, 2023 28,043,449               28,043,449                              
Shareholders' equity, ending balance at Dec. 31, 2023 $ 14,751               $ 3         $ 78,410         $ 0   $ (63,662)   $ 0